Argent Biopharma Ltd (MGCLF)

[cbdstockswatcher]

"Today we’re pleased to report that three landmark milestones have now been met by MGC Pharma.

1. Our CTN (Clinical Trial Notification) for CogniCann™ into Alzheimer’s and dementia at the University of Notre Dame is now available in the Clinical Trials Repository.

2. We are one of the first EU facilities to be granted a full API extraction permit to develop our own THC, CBD and other Phytocannabinoids for use in CannEpil™, CogniCann™ and future phytomedicines.

3. We have received SME certification from the European Medicines Agency (EMA) for the scientific advice, drug evaluation and registration of CannEpil™, CogniCann™ and additional Phytomedicines that the Company is developing.

These are landmark milestones for the MGC Pharma company and are a testament to the continuous hard work we’re putting in to become a global market leader in phytocannabinoids."

Read the full announcement here: http://snip.ly/bx35d9